FTY720: A novel approach to the treatment of hepatic ischemia-reperfusion injury

被引：15

作者：

ANselmo, DM

Amersi, FF

Shen, XD

Gao, F

Katori, M

Ke, B

Lassman, C

Coito, AJ

Brinkmann, V

Busuttil, RW

Kupiec-Weglinski, JW

Farmer, DG

机构：

[1] Univ Calif Los Angeles, Sch Med, Dumont UCLA Transplant Ctr, Los Angeles, CA 90095 USA

[2] Novartis Pharma AG, Transplantat Res, Basel, Switzerland

来源：

TRANSPLANTATION PROCEEDINGS | 2002年 / 34卷 / 05期

关键词：

D O I：

10.1016/S0041-1345(02)02933-0

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：1467 / 1468

页数：2

共 5 条

[1] FTY720: a novel transplantation drug that modulates lymphocyte traffic rather than activation [J].

Brinkmann, V ;

Pinschewer, D ;

Chiba, K ;

Feng, LL .

TRENDS IN PHARMACOLOGICAL SCIENCES, 2000, 21 (02) :49-52

[2] Inhibition of Kupffer cells reduced CXC chemokine production and liver injury [J].

Mosher, B ;

Dean, R ;

Harkema, J ;

Remick, D ;

Palma, J ;

Crockett, E .

JOURNAL OF SURGICAL RESEARCH, 2001, 99 (02) :201-210

[3] Influence of ischemia-reperfusion injury on rejection after liver transplantation [J].

Pirenne, J ;

Gunson, B ;

Khaleef, H ;

Hubscher, S ;

Afford, S ;

McMaster, P ;

Adams, D .

TRANSPLANTATION PROCEEDINGS, 1997, 29 (1-2) :366-367

[4]

SUZUKI S, 1993, TRANSPLANTATION, V55, P1265

[5] CD4(+) T-lymphocytes mediate ischemia/reperfusion-induced inflammatory responses in mouse liver [J].

Zwacka, RM ;

Zhang, YL ;

Halldorson, J ;

Schlossberg, H ;

Dudus, L ;

Engelhardt, JF .

JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (02) :279-289

← 1 →